Generic Name and Formulations:
Oxymetazoline HCl 1%; crm.
Indications for RHOFADE:
Persistent facial erythema associated with rosacea.
≥18yrs: apply a pea-sized amount once daily in a thin layer to entire face (forehead, nose, each cheek, chin). Wash hands after use.
<18yrs: not established.
Not for oral, ophthalmic, or intravaginal use. Avoid eyes, lips, irritated skin, or open wounds. Severe or unstable/uncontrolled cardiovascular disease. Orthostatic hypotension. Uncontrolled hypertension or hypotension. Cerebral or coronary insufficiency. Raynaud's phenomenon. Thromboangiitis obliterans. Scleroderma. Sjögren's syndrome. Increased risk of angle closure glaucoma. Pregnancy. Nursing mothers.
Caution with concomitant beta-blockers, antihypertensives, cardiac glycosides, alpha-1 receptor antagonists. Concomitant MAOIs may affect the metabolism and uptake of circulating amines; caution.
Application site reactions (eg, dermatitis, pruritus, erythema, pain), worsening inflammatory lesions of rosacea.
Gel—30g, 60g (tube or pump)
Endocrinology Advisor Articles
- Soluble Klotho Levels Predictive of Kidney Failure in Type 2 Diabetes
- Clinicians May Be Overtreating Older Patients With Diabetes
- Comorbid and Pharmacologic Factors Increase Risk for Gastrointestinal Disorders in Diabetes
- Obesity Risk in Infants Born to Women With Diabetes
- Increased Risk for Mortality in People With Diabetes, CHD Taking Beta-Blockers
- Diabetes May Decrease Ability to Feel Acid Regurgitation
- Autism Does Not Affect Metabolic Control in Type 1 Diabetes
- Hormonal Contraceptives May Adversely Affect Psychological Health in Adolescent Girls
- Obesity Can Negatively Effect Liver in Children as Young as 8
- Recommendations Developed on Gender Equity in Medicine